For a client receiving terbutaline in preterm labor, what should the nurse consider regarding the administration route?

The administration of terbutaline for clients in preterm labor typically begins with an intravenous (IV) route in an acute care setting since IV delivery allows for rapid onset and tight control over dosing. However, once the initial stabilization is achieved and if ongoing therapy is warranted, it shifts to oral administration for maintenance. This change allows for continuous management of symptoms while avoiding the complications associated with prolonged IV therapy, such as catheter-related infections or fluid overload.

Subcutaneous administration might be an option but is less common in this setting compared to the oral route, which is often preferred for outpatient management once the patient's condition has stabilized. Therefore, transitioning from IV to oral administration reflects a common practice in the management of preterm labor while ensuring patient safety and comfort.